Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Goebeler

Showing results (221-230 of 310) with videos related to

Pageof 31
Sort By:
Molecular and Cellular Biology|January 17, 2003
Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturationMartin Leverkus, Martin R Sprick, Tina Wachter, et al.
The Journal of Investigative Dermatology|February 27, 2018
Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone LymphomaKatja Maurus, Silke Appenzeller, Sabine Roth, et al.
Journal of Cutaneous Pathology|October 12, 2013
Periocular cutaneous oncocytoma with signs of disrupted oxygen metabolismMarion Wobser, Sebastian Haferkamp, Sabine Roth, et al.
Melanoma Research|May 22, 2018
Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitorsAlexander Thiem, Patrick Schummer, Simon Ueberschaar, et al.
Scientific Reports|June 17, 2017
Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigusElias Walter, Franziska Vielmuth, Lukas Rotkopf, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 12, 2019
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expressionAlexander Thiem, Sonja Hesbacher, Hermann Kneitz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 30, 2025
Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysisPatrick Schummer, Caroline Glatzel, Philipp Schrüfer, et al.
The Journal of Investigative Dermatology|May 8, 2020
Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK PathwaysChristian Adam, Lorenza Fusi, Neele Weiss, et al.
Acta Dermato-Venereologica|January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective StudySimon Goller, Tassilo Dege, Patrick Schummer, et al.
The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.
Pageof 31

Showing results (221-230 of 310) with videos related to

Sort By:
Pageof 31
Molecular and Cellular Biology|January 17, 2003
Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturationMartin Leverkus, Martin R Sprick, Tina Wachter, et al.
The Journal of Investigative Dermatology|February 27, 2018
Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone LymphomaKatja Maurus, Silke Appenzeller, Sabine Roth, et al.
Journal of Cutaneous Pathology|October 12, 2013
Periocular cutaneous oncocytoma with signs of disrupted oxygen metabolismMarion Wobser, Sebastian Haferkamp, Sabine Roth, et al.
Melanoma Research|May 22, 2018
Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitorsAlexander Thiem, Patrick Schummer, Simon Ueberschaar, et al.
Scientific Reports|June 17, 2017
Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigusElias Walter, Franziska Vielmuth, Lukas Rotkopf, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 12, 2019
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expressionAlexander Thiem, Sonja Hesbacher, Hermann Kneitz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 30, 2025
Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysisPatrick Schummer, Caroline Glatzel, Philipp Schrüfer, et al.
The Journal of Investigative Dermatology|May 8, 2020
Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK PathwaysChristian Adam, Lorenza Fusi, Neele Weiss, et al.
Acta Dermato-Venereologica|January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective StudySimon Goller, Tassilo Dege, Patrick Schummer, et al.
The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.
Pageof 31